Safety of hLF1-11 for the Treatment of Infectious Complications Among HSCT Recipients

NCT00430469 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Strategic company decision

Conditions

Interventions

Sponsor

AM-Pharma